A portal funded by the National Institutes of Health has added data and more powerful tools to help researchers make scientific breakthroughs in better understanding and treating type 2 diabetes, the most common form of the disease.

Developed in part by a team of scientists and software engineers at the Broad Institute of MIT and Harvard, and the University of Michigan, under NIH’s Accelerating Medicines Partnership, the portal is designed as a central repository for large datasets of human genetic information linked to type 2 diabetes and related traits.

Register or login for access to this item and much more

All Information Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access